![](/img/cover-not-exists.png)
Randomized, Double-Blind, Placebo-Controlled, Phase II Trial of Sorafenib and Erlotinib or Erlotinib Alone in Previously Treated Advanced Non-Small-Cell Lung Cancer
Spigel, D. R., Burris, H. A., Greco, F. A., Shipley, D. L., Friedman, E. K., Waterhouse, D. M., Whorf, R. C., Mitchell, R. B., Daniel, D. B., Zangmeister, J., Bass, J. D., Hainsworth, J. D.Volume:
29
Language:
english
Journal:
Journal of Clinical Oncology
DOI:
10.1200/JCO.2010.30.7678
Date:
June, 2011
File:
PDF, 161 KB
english, 2011